Výsledky vyhledávání - "Emily F N Yuki"

Akademický článek

Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients

Publikováno v: Nature Communications, Vol 13, Iss 1, Pp 1-9 (2022)

Characterising the response to SARS-CoV-2 post vaccination is critical in the appraisement of the induced immune response, performance and protective potential. Here the authors present data from a phase 4 clinical trial in autoimmune rheumatic disea

Externí odkaz: https://doaj.org/article/be9c68c40137469498e931f5f43c71ca

Zobrazit plný text záznamu

Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine

Autor: Nadia E Aikawa, Leonard V K Kupa, Clovis A Silva, Carla G S Saad, Sandra G Pasoto, Emily F N Yuki, Solange R G Fusco, Samuel K Shinjo, Danieli C O Andrade, Percival D Sampaio-Barros, Rosa M R Pereira, Anna C S Chasin, Andrea Y Shimabuco, Ana P Luppino-Assad, Elaine P Leon, Marta H Lopes, Leila Antonangelo, Ana C Medeiros-Ribeiro, Eloisa Bonfa

Publikováno v: Rheumatology. 62:480-485

Objectives To assess immunogenicity of a heterologous fourth dose of an mRNA (BNT162b2) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in autoimmune rheumatic diseases (ARD) patients with poor/non-response to inactivated vaccine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bb7e07f99ede41c2da055d4c31afe4bf
https://doi.org/10.1093/rheumatology/keac301

Zobrazit plný text záznamu

Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study

Autor: Lucas C Netto, Karim Y Ibrahim, Camila M Picone, Ana Paula P S Alves, Eliane V Aniceto, Mariana R Santiago, Patrícia S S Parmejani, Nadia E Aikawa, Ana C Medeiros-Ribeiro, Sandra G Pasoto, Emily F N Yuki, Carla G S Saad, Tatiana Pedrosa, Amanda N Lara, Carina Ceneviva, Eloisa Bonfa, Esper G Kallas, Vivian I Avelino-Silva

Publikováno v: The Lancet HIV. 9:e323-e331

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fd07d5558e82c3bf523b4883a6b647fd
https://doi.org/10.1016/s2352-3018(22)00033-9

Zobrazit plný text záznamu

Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients

Publikováno v: Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP

This randomized controlled study aimed to investigate whether a single bout of exercise before the homologous booster dose of a SARS-CoV-2 inactivated vaccine could enhance immunogenicity in patients with spondyloarthritis. We selected 60 consecutive

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::991f99cfeed757a7502fa16ff7bb9ae1
https://doi.org/10.1152/japplphysiol.00015.2022

Zobrazit plný text záznamu

Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study

Publikováno v: The Lancet. Rheumatology

Background We aimed to examine the immunogenicity pattern induced by the inactivated SARS-CoV-2 vaccine CoronaVac (Sinovac Life Sciences, Beijing, China) in SARS-CoV-2 seropositive patients with autoimmune rheumatic diseases compared with seropositiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::966c3455d3c89828ab8891fa38535dfe
https://doi.org/10.1016/s2665-9913(21)00327-1

Zobrazit plný text záznamu

Strong response after 4th dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine

Autor: Nadia E, Aikawa, Leonard V K, Kupa, Clovis A, Silva, Carla G S, Saad, Sandra G, Pasoto, Emily F N, Yuki, Solange R G, Fusco, Samuel K, Shinjo, Danieli C O, Andrade, Percival D, Sampaio-Barros, Rosa M R, Pereira, Anna C S, Chasin, Andrea Y, Shimabuco, Ana P, Luppino-Assad, Elaine P, Leon, Marta H, Lopes, Leila, Antonangelo, Ana C, Medeiros-Ribeiro, Eloisa, Bonfa

Publikováno v: Rheumatology (Oxford, England).

To assess immunogenicity of a heterologous 4th dose of a mRNA (BNT162b2) SARS-CoV-2 vaccine in autoimmune rheumatic diseases (ARD) patients with poor/non-response to inactivated vaccine (Sinovac-CoronaVac).164 ARD patients who were COVID-19 poor/non-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fcac6f2d01f85f49d71dee3408875c38
https://pubmed.ncbi.nlm.nih.gov/35639644

Zobrazit plný text záznamu

Effect of an Exercise Bout Prior to the Booster Dose of an Inactivated SARS-CoV-2 Vaccine on Immunogenicity in Immunocompromised Patients

This study aimed to investigate whether a single bout of exercise prior to the homologous booster dose of a SARS-CoV-2 inactivated vaccine (Sinovac-CoronaVac) could enhance immunogenicity in patients with dysfunctional immune system. This was a rando

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dbde512bb71129838953e895cb7a95ec
https://doi.org/10.21203/rs.3.rs-1203127/v1

Zobrazit plný text záznamu

Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients

Publikováno v: Nature communications. 13(1)

The determination of durability and vaccine-associated protection is essential for booster doses strategies, however data on the stability of SARS-CoV-2 immunity are scarce. Here we assess anti-SARS-CoV-2 immunogenicity decay and incident cases six m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dee55b24ef440d8f2142afdb19f39b8
https://pubmed.ncbi.nlm.nih.gov/36192386

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání